The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase
Open accessAbstract
Telomeres, the physical ends of eukaryotes chromosomes are transcribed into telomeric repeat containing RNA (TERRA), a large non-coding RNA of unknown function, which forms an integral part of telomeric heterochromatin. TERRA molecules resemble in sequence the telomeric DNA substrate as they contain 5'-UUAGGG-3' repeats near their 3'-end which are complementary to the template sequence of telomerase RNA. Here we demonstrate that endogenous TERRA is bound to human telomerase in cell extracts. Using in vitro reconstituted telomerase and synthetic TERRA molecules we demonstrate that the 5'-UUAGGG-3' repeats of TERRA base pair with the RNA template of the telomerase RNA moiety (TR). In addition TERRA contacts the telomerase reverse transcriptase (TERT) protein subunit independently of hTR. In vitro studies further demonstrate that TERRA is not used as a telomerase substrate. Instead, TERRA acts as a potent competitive inhibitor for telomeric DNA in addition to exerting an uncompetitive mode of inhibition. Our data identify TERRA as a telomerase ligand and natural direct inhibitor of human telomerase. Telomerase regulation by the telomere substrate may be mediated via its transcription.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 1×
“Since direct telomerase assays do not involve PCR amplification as done in the TRAP assay (22), information on telomerase processivity can be obtained (see below).”
BackgroundIdentification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400 · cited 2×
“Alternatively or in addition, it is conceivable that telomeric heterochromatin bound TERRA binds and sequesters telomerase [Figure 6; scenario (2)].”
BackgroundTelomeric Repeat–Containing RNA and RNA Surveillance Factors at Mammalian Chromosome Ends
Azzalin, C. M., Reichenbach, P., Khoriauli, L., Giulotto, E., & Lingner, J. (2007) · Science · doi:10.1126/science.1147182 · Cited by 1,329
Self-citationHow Telomeres Solve the End-Protection Problem
de Lange, T. (2009) · Science · doi:10.1126/science.1170633 · Cited by 826
Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II
Schoeftner, S., & Blasco, M. A. (2008) · Nature Cell Biology · doi:10.1038/ncb1685 · Cited by 791
Protein Composition of Catalytically Active Human Telomerase from Immortal Cells
Cohen, S. B., Graham, M. E., Lovrecz, G. O., Bache, N., Robinson, P. J., & Reddel, R. R. (2007) · Science · doi:10.1126/science.1138596 · Cited by 669
The epigenetic regulation of mammalian telomeres
Blasco, M. A. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2047 · Cited by 600
A highly selective telomerase inhibitor limiting human cancer cell proliferation
Damm, K., Hemmann, U., Garin‐Chesa, P., Hauel, N., Kauffmann, I., Priepke, H., Niestroj, C., Daiber, C., Enenkel, B., Guilliard, B., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6958 · Cited by 422
Self-citationBeginning to Understand the End of the Chromosome
Cech, T. R. (2004) · Cell · doi:10.1016/s0092-8674(04)00038-8 · Cited by 421
Mechanism of Human Telomerase Inhibition by BIBR1532, a Synthetic, Non-nucleosidic Drug Candidate
Pascolo, E., Wenz, C., Lingner, J., Hauel, N., Priepke, H., Kauffmann, I., Garin-Chesa, P., Rettig, W. J., Damm, K., & Schnapp, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201266200 · Cited by 326
Self-citation
Cited by
Molecular Mechanisms of Long Noncoding RNAs
Wang, K. C., & Chang, H. Y. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.018 · Cited by 4,396
The hallmarks of cancer: A long non-coding RNA point of view
Gutschner, T., & Diederichs, S. (2012) · RNA Biology · doi:10.4161/rna.20481 · Cited by 1,802
Long noncoding RNAs and the genetics of cancer
Cheetham, S. W., Gruhl, F., Mattick, J. S., & Dinger, M. E. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.233 · Cited by 724
Targeting noncoding RNAs in disease
Adams, B. D., Parsons, C., Walker, L., Zhang, W. C., & Slack, F. J. (2017) · Journal of Clinical Investigation · doi:10.1172/jci84424 · Cited by 673
Therapeutic Targeting of Long Non-Coding RNAs in Cancer
Arun, G., Diermeier, S. D., & Spector, D. L. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.01.001 · Cited by 611
The application of DNA and RNA G-quadruplexes to therapeutic medicines
Collie, G. W., & Parkinson, G. N. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15067g · Cited by 589
Long noncoding RNAs in cancer: mechanisms of action and technological advancements
Bartonicek, N., Maag, J. L. V., & Dinger, M. E. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0530-6 · Cited by 459
The bright side of dark matter: lncRNAs in cancer
Evans, J. R., Feng, F. Y., & Chinnaiyan, A. M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84421 · Cited by 451
Epigenetics and cardiovascular disease
Ordovás, J. M., & Smith, C. E. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.104 · Cited by 402
Long noncoding RNAs: Novel insights into hepatocelluar carcinoma
He, Y., Meng, X.-M., Huang, C., Wu, B.-M., Zhang, L., Lv, X.-W., & Li, J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.10.021 · Cited by 385
Telomere Biology and Human Phenotype
Turner, K., Vasu, V., & Griffin, D. (2019) · Cells · doi:10.3390/cells8010073 · Cited by 385
The Molecular Interactions That Stabilize RNA Tertiary Structure: RNA Motifs, Patterns, and Networks
Butcher, S. E., & Pyle, A. M. (2011) · Accounts of Chemical Research · doi:10.1021/ar200098t · Cited by 362
TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA
Flynn, R. L., Centore, R. C., O’Sullivan, R. J., Rai, R., Tse, A., Songyang, Z., Chang, S., Karlseder, J., & Zou, L. (2011) · Nature · doi:10.1038/nature09772 · Cited by 342
Basic biology and therapeutic implications of lncRNA
Khorkova, O., Hsiao, J., & Wahlestedt, C. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.012 · Cited by 341
Chemistry in human telomere biology: structure, function and targeting of telomere DNA/RNA
Xu, Y. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00134a · Cited by 323
Human telomerase: biogenesis, trafficking, recruitment, and activation
Schmidt, J. C., & Cech, T. R. (2015) · Genes & Development · doi:10.1101/gad.263863.115 · Cited by 301
Telomere Length Determines TERRA and R-Loop Regulation through the Cell Cycle
Graf, M., Bonetti, D., Lockhart, A., Serhal, K., Kellner, V., Maicher, A., Jolivet, P., Teixeira, M. T., & Luke, B. (2017) · Cell · doi:10.1016/j.cell.2017.06.006 · Cited by 292
Long Noncoding RNAs: Emerging Stars in Gene Regulation, Epigenetics and Human Disease
Bhan, A., & Mandal, S. S. (2014) · ChemMedChem · doi:10.1002/cmdc.201300534 · Cited by 279
Millevoi, S., Moine, H., & Vagner, S. (2012) · WIREs RNA · doi:10.1002/wrna.1113 · Cited by 277
TERRA RNA Antagonizes ATRX and Protects Telomeres
Chu, H.-P., Cifuentes-Rojas, C., Kesner, B., Aeby, E., Lee, H.-G., Wei, C., Oh, H. J., Boukhali, M., Haas, W., & Lee, J. T. (2017) · Cell · doi:10.1016/j.cell.2017.06.017 · Cited by 275
Long Noncoding RNAs in Cardiovascular Pathology, Diagnosis, and Therapy
Bär, C., Chatterjee, S., & Thum, T. (2016) · Circulation · doi:10.1161/circulationaha.116.023686 · Cited by 267
Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets
Fatima, R., Akhade, V. S., Pal, D., & Rao, S. M. (2015) · Molecular and Cellular Therapies · doi:10.1186/s40591-015-0042-6 · Cited by 263
Non-Coding RNAs: Multi-Tasking Molecules in the Cell
Gomes, A., Nolasco, S., & Soares, H. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140816010 · Cited by 261
Telomere length regulates TERRA levels through increased trimethylation of telomeric H3K9 and HP1α
Arnoult, N., Van Beneden, A., & Decottignies, A. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2364 · Cited by 258
Zhu, Y., Liu, X., Ding, X., Wang, F., & Geng, X. (2019) · Biogerontology · doi:10.1007/s10522-018-9769-1 · Cited by 255
The Role of Telomere Biology in Cancer
Xu, L., Li, S., & Stohr, B. A. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-164030 · Cited by 160
Genetic and epigenetic regulation of human aging and longevity
Morris, B. J., Willcox, B. J., & Donlon, T. A. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.039 · Cited by 140
Telomerase efficiently elongates highly transcribing telomeres in human cancer cells
Farnung, B. O., Brun, C. M., Arora, R., Lorenzi, L. E., & Azzalin, C. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035714 · Cited by 91
Role of TERRA in the regulation of telomere length
Wang, C., Zhao, L., & Lu, S. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.10528 · Cited by 89
Cifuentes-Rojas, C., & Shippen, D. E. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.10.003 · Cited by 64
Telomeres, a busy platform for cell signaling.
Gardano, L., Pucci, F., Christian, L., Le Bihan, T., & Harrington, L. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00146 · Cited by 15
“Because of their ability to anneal with the template sequence in the telomerase RNA component, TERRAs are able to inhibit telomerase (Figure 1B) (Redon et al., 2010).”
Background
Metadata
- Authors
- Redon, S., Reichenbach, P., & Lingner, J.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-05-11
- Volume
- 38
- Issue
- 17
- Pages
- 5797-5806
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2137986693
- Cited by
- 385
- References
- 32
- FWCI
- 17.12
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.